• Investing Ideas
  • /
  • South Korean Pharmaceuticals & Biotech Potentially Undervalued Companies
32 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A214450

PharmaResearch
₩127,600.0010.5%23.3%₩1.3t₩175,000.00PE17xE20.5%0.7%

A185750

Chong Kun Dang Pharmaceutical
₩104,300.002.5%29.6%₩1.3t₩152,333.33PE6.3xE-23.6%1.0%

A069620

Daewoong Pharmaceutical
₩111,900.000.3%1.8%₩1.3t₩156,625.00PE10.6xE1.2%0.5%

A038290

Macrogen
₩20,300.001.5%3.2%₩202.6b₩30,000.00PS1.5xE112.4%1.5%

A000640

Dong-A Socio Holdings
₩110,500.00-3.4%35.3%₩690.7b₩155,000.00PE11.9xE14.8%2.2%

A243070

Huons
₩34,500.000.3%7.6%₩409.6b₩54,000.00PE8.1xE9.1%1.9%

A003220

Daewon Pharmaceutical
₩14,960.00-0.7%0%₩317.1b₩21,000.00PE13.3xE23.8%2.3%

A249420

Ildong Pharmaceutical
₩15,530.004.4%-22.7%₩433.8b₩25,000.00PB2.6xE75.9%0%

A023910

Daihan PharmaceuticalLtd
₩28,450.00-0.2%2.2%₩167.3b₩40,500.00PE5.9xE7.7%2.6%

A142760

MOA Life Plus
₩4,075.007.8%-3.7%₩153.8bn/aPS8.4xn/an/a

A950200

Psomagen
₩4,885.00-0.7%-28.4%₩94.0bn/aPS2.9xn/an/a

A012790

Sinil Pharmaceutical
₩7,100.000.3%-10.7%₩80.8bn/aPE5.9xn/a2.4%

A096760

JW Holdings
₩3,015.000%-5.4%₩217.8bn/aPE11.4xn/a3.5%

A086450

DongKook Pharmaceutical
₩16,480.001.0%8.6%₩724.5b₩24,000.00PE15.4xE16.2%1.1%

A234080

JW Lifescience
₩12,450.000.9%4.9%₩192.8bn/aPE6.8xn/a4.0%

A003850

Boryung
₩11,150.002.2%31.2%₩740.4b₩15,333.33PE18.4xE31.8%0.9%

A068270

Celltrion
₩189,000.005.3%18.9%₩39.2t₩230,117.65PE73.1xE40.3%0.3%

A216080

JETEMA
₩15,640.004.4%-22.4%₩279.3b₩28,000.00PE20xE38.9%n/a

A086060

GeneBioTech Ltd
₩3,880.000%-9.1%₩33.4bn/aPE12.9xn/a0%

A006280

GC Biopharma
₩114,300.002.5%-6.3%₩1.3t₩144,666.67PB1xE82.3%1.3%

A007370

Jin Yang Pharmaceutical
₩5,470.000.2%-9.3%₩59.0bn/aPE4.7xn/a2.7%

A001630

Chong Kun Dang Holdings
₩61,600.00-1.1%20.8%₩293.3b₩63,000.00PE6.2xE-65.8%2.3%

A377740

BioNote
₩4,115.000.4%-32.9%₩420.0bn/aPS4.7xn/a11.9%

A206650

EuBiologics
₩13,390.00-0.4%86.8%₩488.5b₩15,000.00PS7xE93.4%n/a
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.